Leg­end's new CMO will bring in more cell ther­a­py part­ners; Pre­ci­sion founders get back in Tune to­geth­er

Mythili Koneru re­turned to her child­hood stomp­ing grounds of New Jer­sey last Fri­day to lead the med­ical op­er­a­tions at Leg­end Biotech, where she’ll dri­ve the cell ther­a­py mak­er’s ex­pan­sion in­to sol­id tu­mors and off-the-shelf op­tions.

Leg­end will tap in­to her busi­ness de­vel­op­ment chops, built dur­ing a stint at Eli Lil­ly, as it looks to ink more part­ner­ships on the back of its suc­cess­ful col­lab­o­ra­tion with John­son & John­son‘s Janssen, which helped so­lid­i­fy the biotech as one of the ear­ly lead­ers in cell ther­a­py with the ap­proval of Carvyk­ti.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER